Investigational drug · Phase 2
PRX-115
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Gout.
Phase 2Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "PRX-115"
First trial start
2025
Dec 22, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "PRX-115", any sponsor or status.
Conditions studied
As listed on its trial records.
- Gout
Approved drugs for the same conditions: Gout
Largest trials
Live from ClinicalTrials.gov: studies naming "PRX-115" as an intervention, largest first.
- A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)Pivotal-lookingRecruiting
ProtalixIndustry
NCT07280156 · 150 participants (planned) · Start Dec 22, 2025 · Primary completion Dec 2027
Drug: PRX-115; Methotrexate (MTX) · For: Gout
Sites: Glendale, Arizona; Little Rock, Arkansas; Anaheim, California · 35 sites in all
ProtalixIndustry
NCT05745727 · 64 participants · Start Mar 23, 2023 · Primary completion Aug 26, 2024
Drug: PRX-115; Placebo · For: Gout
Sites: Grafton, New Zealand; Christchurch, New Zealand
Newest research
PubMed records naming it or its code names, newest first.
- Updates in uricase therapy for gout.
Schlesinger N, Kaufmann D · Curr Opin Rheumatol 2025
Also in development for Gout
- AR882Phase 33 trials
Arthrosi Therapeutics · Gout, Hyperuricemia, Gout Chronic
- DotinuradPhase 33 trials
Crystalys Therapeutics · Gout, Tophaceous Gout
- TigulixostatIBI128, LC350189Phase 33 trials
Innovent Biologics Technology Limited (Shanghai R&D Center) · Gout, Hyperuricemia, Gout Flare
- ABP-671Phase 32 trials
Atom Therapeutics Co., Ltd · Chronic Kidney Disease, Gout
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.